QDEL - Quidel more quick diagnosis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QDEL - Quidel more quick diagnosis

QDEL 22.60

+3.2%

Nov 12 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Keiko who wrote (1348)	1/24/1998 7:12:00 PM
From: Mike Relyea	of 1693

Keiko, Indirectly the Quidel's third quarter earnings report should be reassuring to Trinity's investors. The report and information Mr. Frankel provided in the conference call indicates Quidel's CLIA approved Strep A and H. pylori POC tests sales are increasing, and they continue to capture more market share. If these tests were not doing as well as expected investors probably would not place much value on similar POC tests to be marketed in the U.S., following approvals, by Trinity. Mike

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next